BMY Bristol Myers Squibb Co

Bristol-Myers Squibb Co. (BMY) is currently at $45.32, up $2.10 or 4.85%

-- Would be highest close since July 10, 2019, when it closed at $45.96

-- On pace for largest percent increase since Feb. 15, 2018, when it rose 5.55%

-- Earlier Thursday, Bristol-Myers Squibb reported a profit for the second quarter of $1.43 billion, or 87 cents a share, up from $373 million, or 23 cents a share, a year earlier. Excluding one-time items, earnings were $1.18 a share, above the $1.06 a share analysts polled by FactSet were looking for

-- The earnings report came after the company had released disappointing data after the market closed on Wednesday on a trial involving its cancer drug Opdivo and appears to have cushioned the blow from the Opdivo news

-- Currently up three consecutive days; up 5.97% over this period

-- Best three day stretch since the three days ending March 1, 2019, when it rose 6.1%

-- Down 0.06% month-to-date; on pace for worst month since May 2019, when it fell 2.28%

-- Down 12.8% year-to-date

-- Up 5.97% from its 52 week closing low of $42.77 on July 22, 2019

-- Traded as high as $45.37; highest intraday level since July 11, 2019, when it hit $45.89

-- Up 4.95% at today's intraday high; largest intraday percent increase since Jan. 4, 2019, when it rose as much as 5.39%

-- Third best performer in the S&P 500 today

-- Eighth most active stock in the S&P 500 today

All data as of 11:08:50 AM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 25, 2019 11:34 ET (15:34 GMT)

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024

Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024